{
  "trial_id": "NCT00552409",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Race/Ethnicity, Body Mass Index (BMI), Duration of Diabetes, Baseline Hemoglobin A1c, Baseline Blood Pressure, Baseline Estimated Glomerular Filtration Rate (eGFR), Baseline Urine Albumin-Creatinine Ratio, Baseline Serum Calcium, Baseline 25-Hydroxyvitamin D Levels, Use of Angiotensin Converting Enzyme Inhibitor, Use of Angiotensin II Receptor Blocker, Baseline Cardiovascular Risk Markers",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Body Mass Index (BMI)",
        "Duration of Diabetes",
        "Baseline Hemoglobin A1c",
        "Baseline Blood Pressure",
        "Baseline Estimated Glomerular Filtration Rate (eGFR)",
        "Baseline Urine Albumin-Creatinine Ratio",
        "Baseline Serum Calcium",
        "Baseline 25-Hydroxyvitamin D Levels",
        "Use of Angiotensin Converting Enzyme Inhibitor",
        "Use of Angiotensin II Receptor Blocker",
        "Baseline Cardiovascular Risk Markers"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Hemoglobin A1c, Estimated Glomerular Filtration Rate (eGFR), Urine Albumin-Creatinine Ratio, Serum Calcium, 25-Hydroxyvitamin D Levels, Use of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Hemoglobin A1c",
        "Estimated Glomerular Filtration Rate (eGFR)",
        "Urine Albumin-Creatinine Ratio",
        "Serum Calcium",
        "25-Hydroxyvitamin D Levels",
        "Use of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Duration, HbA1c, Blood Pressure, eGFR, Urine Albumin-Creatinine Ratio, 25-Hydroxyvitamin D, BMI, History of Cardiovascular Disease, History of Kidney Disease,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Diabetes Duration",
        "HbA1c",
        "Blood Pressure",
        "eGFR",
        "Urine Albumin-Creatinine Ratio",
        "25-Hydroxyvitamin D",
        "BMI",
        "History of Cardiovascular Disease",
        "History of Kidney Disease"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index, duration of diabetes, duration of kidney disease, hemoglobin A1c, systolic blood pressure, diastolic blood pressure, estimated glomerular filtration rate, urine albumin-creatinine ratio, 25-hydroxyvitamin D level, serum calcium level, history of cardiovascular disease, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index",
        "duration of diabetes",
        "duration of kidney disease",
        "hemoglobin A1c",
        "systolic blood pressure",
        "diastolic blood pressure",
        "estimated glomerular filtration rate",
        "urine albumin-creatinine ratio",
        "25-hydroxyvitamin D level",
        "serum calcium level",
        "history of cardiovascular disease",
        "smoking status"
      ]
    }
  }
}